CLINICAL RESEARCH ADVANTAGE Trademark

Trademark Overview

On Friday, August 3, 2007, a trademark application was filed for CLINICAL RESEARCH ADVANTAGE with the United States Patent and Trademark Office. The USPTO has given the CLINICAL RESEARCH ADVANTAGE trademark a serial number of 77247167. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 17, 2020. This trademark is owned by Clinical Research Advantage. The CLINICAL RESEARCH ADVANTAGE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research for pharmaceutical companies, namely, the research and development of new drug technologies
clinical research advantage

General Information

Serial Number77247167
Word MarkCLINICAL RESEARCH ADVANTAGE
Filing DateFriday, August 3, 2007
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 17, 2020
Registration Number3637316
Registration DateTuesday, June 16, 2009
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 31, 2009

Trademark Statements

Indication of Colors claimedThe color(s) green and black is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"CLINICAL RESEARCH"
Description of MarkThe mark consists of the wording "CLINICAL RESEARCH ADVANTAGE" in black with the tail of the letter "G" in "ADVANTAGE" shaped like a heart. To the left of the wording, a green stylized heart design appears.
Goods and ServicesScientific research for pharmaceutical companies, namely, the research and development of new drug technologies

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 17, 2020
Primary Code042
First Use Anywhere DateSunday, May 30, 1999
First Use In Commerce DateSunday, May 30, 1999

Trademark Owner History

Party NameClinical Research Advantage
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTempe, AZ 85282
Party NameClinical Research Advantage
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTempe, AZ 85282
Party NameClinical Research Advantage
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressScottsdale, AZ 85258

Trademark Events

Event DateEvent Description
Friday, January 17, 2020CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, June 16, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, September 30, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, September 9, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, June 17, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, March 31, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, March 31, 2015REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, March 31, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, March 19, 2015TEAS SECTION 8 & 15 RECEIVED
Tuesday, June 16, 2009REGISTERED-PRINCIPAL REGISTER
Friday, May 22, 2009APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 22, 2009TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 27, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 27, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 31, 2009PUBLISHED FOR OPPOSITION
Wednesday, March 11, 2009NOTICE OF PUBLICATION
Monday, February 23, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, February 23, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 23, 2009EXAMINER'S AMENDMENT ENTERED
Monday, February 23, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, February 23, 2009EXAMINERS AMENDMENT E-MAILED
Monday, February 23, 2009EXAMINERS AMENDMENT -WRITTEN
Saturday, February 7, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, February 7, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 6, 2009TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, February 6, 2009EX PARTE APPEAL-INSTITUTED
Friday, February 6, 2009JURISDICTION RESTORED TO EXAMINING ATTORNEY
Friday, February 6, 2009EXPARTE APPEAL RECEIVED AT TTAB
Thursday, December 18, 2008NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, December 18, 2008FINAL REFUSAL E-MAILED
Thursday, December 18, 2008FINAL REFUSAL WRITTEN
Friday, November 28, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 28, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 28, 2008ASSIGNED TO LIE
Tuesday, November 18, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, June 7, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, June 7, 2008NON-FINAL ACTION E-MAILED
Saturday, June 7, 2008NON-FINAL ACTION WRITTEN
Friday, May 9, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 9, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 9, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 9, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 9, 2007NON-FINAL ACTION E-MAILED
Friday, November 9, 2007NON-FINAL ACTION WRITTEN
Thursday, November 8, 2007ASSIGNED TO EXAMINER
Thursday, August 9, 2007NOTICE OF DESIGN SEARCH CODE MAILED
Wednesday, August 8, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

advantage research clinical drug technologies development companies pharmaceutical scientific namely